Markets:

Overview

News

Currencies

International

Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

60.23 +1.81 (+3.10%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

43 44 Next >

3 New ETFs Finding Early Traction With Investors

April 21, 2025

Markets have tumbled in 2025, but three funds launched this year have the potential to outshine even longer-established ETFs.

Via MarketBeat

Topics ETFs

10 Worst Performing Large-Caps Last 12 Months ↗

April 19, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders

April 18, 2025

From Johnson Fistel, PLLP

Via Business Wire

DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

April 17, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Tariffs, Trump, and Turmoil ↗

April 16, 2025

Via The Motley Fool

Topics Economy Government World Trade

What Does the Market Think About DexCom? ↗

April 11, 2025

Via Benzinga

10 Worst Performing Large-Caps Last 12 Months ↗

April 10, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

What's going on in today's session: S&P500 movers ↗

April 10, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch ↗

April 10, 2025

Dexcom G7 15-Day CGM approved by FDA for adults with diabetes; U.S. launch set for late 2025 with extended wear and advanced tracking features.

Via Benzinga

2 Growth Stocks to Buy in the Tariff-Fueled Market Correction ↗

April 10, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday ↗

April 10, 2025

Via Benzinga

Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device ↗

April 10, 2025

Dexcom stock surged Thursday after the FDA cleared its newest diabetes device for an extended 15-day wear time.

Via Investor's Business Daily

Topics Government Stocks World Trade

Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System

April 10, 2025

From DexCom, Inc.

Via Business Wire

What 6 Analyst Ratings Have To Say About DexCom ↗

April 10, 2025

Via Benzinga

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

April 08, 2025

Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry ↗

April 04, 2025

Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies...

Via Benzinga

Topics Government World Trade

Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time.

April 03, 2025

From DexCom, Inc.

Via Business Wire

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

April 03, 2025

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

Via StockStory

Topics Artificial Intelligence

10 Worst Performing Large-Caps Last 12 Months ↗

March 27, 2025

Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.

Via Talk Markets

Topics Stocks / Equities

The Future of Healthcare: 10 Predictions For The Next Decade

March 27, 2025

The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we...

Via MarketMinute

Topics Artificial Intelligence

Dexcom Appoints Jon Coleman as Chief Commercial Officer

March 25, 2025

From DexCom, Inc.

Via Business Wire

Tuesday's session: top gainers and losers in the S&P500 index ↗

March 25, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

Via Chartmill

Why DEXCOM INC (NASDAQ:DXCM) Is a Standout High-Growth Stock in a Consolidation Phase. ↗

March 24, 2025

Based on a technical and fundamental analysis of NASDAQ:DXCM we ask: Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

DexCom (DXCM): 3 Reasons We Love This Stock

March 24, 2025

Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their next...

Via StockStory

Topics Stocks

Is DexCom Gaining or Losing Market Support? ↗

March 21, 2025

Via Benzinga

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

March 21, 2025

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Via StockStory

Topics Artificial Intelligence

Exploring the top movers within the S&P500 index during today's session. ↗

March 20, 2025

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Top S&P500 movers in Thursday's session ↗

March 20, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next ↗

March 19, 2025

Via The Motley Fool

Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care

March 19, 2025

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

43 44 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

DexCom, Inc. - Common Stock (NQ:DXCM)

All News about DexCom, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today